<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0009308'>Adenocarcinomas</z:mp> of lower oesophagus, gastro-oesophageal junction and cardia in humans are highly invasive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> with poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>The localisation of urokinase-type plasminogen activator receptor (uPAR) was determined in 66 patients; 60 with <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> and six cases with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>uPAR was expressed in nearly <z:hpo ids='HP_0000001'>all</z:hpo> cases of invasive <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> by populations of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, macrophages and myofibroblasts at both the invasion front and the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> core </plain></SENT>
<SENT sid="3" pm="."><plain>In areas with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or with Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> adjacent to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue, no uPAR-immunoreactivity was found </plain></SENT>
<SENT sid="4" pm="."><plain>High local expression of uPAR, therefore, appears to be a characteristic marker for invasive behaviour in this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>, suggesting that uPAR's contribution to matrix degradation during invasive growth is a late event in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Using a scoring system for semiquantitative estimation of uPAR-positivity on immmunohistochemically stained specimens, a significant association was found between poor overall survival and high uPAR-score for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> core and for macrophages peripherally at the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> invasion zone </plain></SENT>
<SENT sid="6" pm="."><plain>In multivariate analysis, these two uPAR-scores were confirmed as highly significant prognostic parameters independent of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumour</z:e>, Node, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastasis</z:e> (TNM)-stage and World Health Organization (WHO) classification </plain></SENT>
<SENT sid="7" pm="."><plain>The proteolytic action of these malignant and nonmalignant accessory cells thus seemed to follow two main patterns: one dominated by uPAR positive <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells and one by uPAR-positive macrophages </plain></SENT>
<SENT sid="8" pm="."><plain>Scoring of uPAR-positivity might be a useful parameter for <z:hpo ids='HP_0003674'>onset</z:hpo> of invasion and prognosis in these <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
</text></document>